Are electronic signatures legally enforceable?

Yes. Electronic signatures are legally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state UETA laws where adopted; ensure intent, consent, attribution, and reproducible records to meet the legal validity test.

Is a HIPAA Business Associate Agreement required?

Execute a BAA whenever a vendor will create, receive, maintain, or transmit protected health information on behalf of a covered entity. Verify the vendor’s HIPAA compliance posture and obtain a signed BAA before sharing PHI.

Can informed consent be completed electronically?

Electronic informed consent is acceptable when the consent process meets IRB standards and ESIGN requirements, including any consumer-disclosure obligations; document participant access, consent version, and the consent date for auditability.

What signer authentication methods are appropriate?

Acceptable authentication ranges from email links and SMS codes to multi-factor authentication and knowledge-based checks. For regulated records consider stronger methods and follow any applicable 21 CFR Part 11 or sponsor-specific authentication requirements.

How should signed forms be stored and retained?

Store signed records with tamper-evident PDFs, audit trails, and access controls. Retention follows federal standards (HIPAA six years, IRS three years) and sponsor or state requirements; preserve audit data and version history.

What if a participant cannot sign electronically?

Provide alternatives such as witnessed paper signatures, scanned uploads, or assisted signing. Obtain documented consent to use electronic records per ESIGN and record the alternative method used to establish signer intent.

Electronic Signature
Templates
Healthcare
Healthcare Research Form

Healthcare Research Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE RESEARCH FORM

Study Identification

Study Title Sponsor / Funding Entity Principal Investigator

Investigator Contact — Phone: Email:

Participant Information

Participant Full Name

Date of Birth: Gender:

Address

Phone: Alternate Phone:

Emergency Contact

Relation: Phone:

Insurance Information

Primary Insurance Provider

Policy Number: Group Number:

Subscriber Name (if different)

Medical History

Current Medications Known Allergies Prior Surgeries / Hospitalizations Chronic Conditions

Description of Research Procedures

Summary of Procedures

Estimated number of study visits: Expected study duration:

Risks, Benefits, and Alternatives

I understand the investigator has explained the reasonably foreseeable risks and discomforts associated with participation, which may include but are not limited to: adverse reactions to study procedures, unexpected findings, and breaches of confidentiality despite safeguards. I acknowledge that benefits are not guaranteed and may include increased monitoring, access to investigational interventions, or contribution to generalizable knowledge.

I acknowledge that the risks and benefits were explained to me and I have had the opportunity to ask questions.

Confidentiality and Use of Data

All study records will be maintained in secure systems. Identifiable information will be accessible to the investigative team and authorized study monitors. De-identified data may be used for future research or shared with collaborators; such de-identified data will not contain direct identifiers.

I consent to the use of de-identified data and biological samples for future research consistent with protocol objectives.

I consent to collection and storage of biological samples for analysis as described in the study.

I consent to genetic testing on collected samples (optional). I understand genetic testing may reveal information relevant to health, ancestry, or disease risk and that counseling may be offered.

HIPAA Authorization for Use and Disclosure of Protected Health Information

By checking the box below, I authorize the release of my protected health information to the study team for purposes of recruitment, study conduct, monitoring, and analysis. This authorization includes medical records, laboratory results, imaging, and other records as necessary for the research described above.

I authorize the use and disclosure of my protected health information as described above.

Voluntary Participation and Withdrawal

I understand my participation is voluntary. I may refuse to participate or withdraw at any time without penalty or loss of benefits to which I am otherwise entitled. Withdrawal will not affect the use of information collected prior to withdrawal unless I specifically request destruction of identifiable data, which may be limited by regulatory or safety requirements.

Compensation and Costs

The study will provide the following compensation or reimbursement for study-related expenses:

I understand that any routine clinical care not specified in this protocol may be billed to my insurance or myself. The study team has explained which procedures, if any, are study-related and will be covered by the study.

Emergency Treatment

In the event of an emergency arising from study procedures, study personnel may arrange for medical treatment. I understand I am responsible for costs of emergency care not covered by the study unless otherwise stated.

Authorization Duration

This authorization and consent remain in effect until the following expiration date, event, or indefinite if left blank.

Participant Rights and Certifications

I certify that I have read (or had read to me) the information above, the nature and purpose of the research have been explained, and my questions have been answered to my satisfaction. I understand that I will be given a signed copy of this form upon request. I understand that I may contact the principal investigator for additional information concerning the study, my rights as a research participant, or if I experience a research-related injury.

Additional Notes (optional)

Patient Printed Name:

Signature:

If signed by guardian, Relationship to Participant:

Date:

What the Healthcare Research Form Is and When it’s Used

The Healthcare Research Form is a standardized document used to collect participant data, document informed consent, and record study procedures for clinical and observational research. It combines demographic information, eligibility screening, consent language, data-use permissions, and any study-specific measurements that may include protected health information subject to HIPAA. Investigators, research coordinators, sponsors, and institutional review boards rely on the form to document enrollment, support data integrity, and create an auditable record for regulatory review and retention requirements.

Why a Standardized Healthcare Research Form Matters

Using a consistent Healthcare Research Form improves data quality, accelerates IRB review, and documents participant consent and data-use permissions clearly. Well-structured forms reduce follow-up queries, support regulatory audits, and help ensure PHI is managed according to HIPAA and institutional policies.

Who Typically Prepares and Signs This Form

Typical users include clinical investigators, IRB administrators, research coordinators, data managers, and sponsoring organizations managing study enrollment and compliance.

Academic researchers and clinical investigators leading protocol development and participant enrollment.
Institutional review boards and ethics committees reviewing consent language and data-protection measures.
Sponsors, contract research organizations, and data managers responsible for regulatory reporting and secure data transfers.

Choosing the correct version and completing required fields accurately affects enrollment pace, audit readiness, and the legal defensibility of study records.

Core Sections a Professional Healthcare Research Form Should Include

Essential components of a professional Healthcare Research Form ensure consent clarity, data integrity, participant safeguards, and administrative traceability for clinical and observational studies.

Enrollment Info

Collect full legal name, contact details, date of birth, and site-specific study identifier. Accurate enrollment fields enable reliable linkage with case report forms and minimize mismatched participant records during analysis and monitoring.

Informed Consent

Present study purpose, procedures, risks, benefits, and withdrawal instructions in plain language. Consent must include explicit data-sharing permissions and reflect IRB-reviewed language to meet human subjects protections.

PHI / Data Elements

List only necessary protected health information fields and justify collection purpose. Prefer coded identifiers where feasible and document PHI handling to support HIPAA-compliant processing and BAAs when required.

Eligibility Criteria

Include concise inclusion and exclusion criteria, screening checkboxes, and reviewer initials to reduce enrollment errors and to create a reproducible record of participant eligibility decisions.

Signatures & Dates

Provide distinct signature blocks for participant, legally authorized representative, and investigator with role labels and dates to establish consent validity and a clear timeline for study entry.

Audit Trail

Maintain version control, reviewer notes, and a signature history with timestamps and signer attribution to support audits, monitoring visits, and regulatory inspections.

Security and Data Handling Checklist

PHI Handling: Limit storage and sharing of PHI

Encryption: AES-256 at rest; TLS 1.2/1.3 in transit

Access Controls: Role-based access and MFA for signers

Audit Logs: Maintain detailed audit trails and timestamps

BAA Requirement: Execute BAA when HIPAA data involved

Data Minimization: Collect only required data elements

Step-by-Step: Completing and Submitting the Form

Follow these steps to complete and submit the Healthcare Research Form accurately and efficiently online or on paper.

01

Prepare Documents: Gather protocol, consent, and sponsor instructions.
02

Complete Fields: Fill required fields and use MM/DD/YYYY formats.
03

Obtain Signatures: Participant and investigator sign and date.
04

Submit Records: Send to IRB, sponsor, and retain copies.

Routing Flow: From Completion to Archival

This flow outlines routing from form completion through archiving and reporting for research records and audits.

Completion: Staff completes fields and verifies eligibility.
Authentication: Signers authenticate by email link or MFA.
Submission: Submit to IRB portal or sponsor system.
Archiving: Store signed PDF with audit trail and access controls.

Suggested eSubmission and eSignature Configuration

Suggested online configuration for e-submission and eSignature workflows for the Healthcare Research Form, including authentication and retention settings.

Field Name and Configuration Setting	Field \| Configuration
Primary signer authentication selection	Authentication \| Email link; enable SMS or MFA when required
Signature appearance and timestamp options	Appearance \| Visible signature overlay with secure timestamp
Conditional fields and validation rules configuration	Fields \| Use conditional logic and required validation rules
Retention and export settings for archives	Retention \| Export signed PDF and CSV, store encrypted

Platform Requirements for eSubmission and Compliance

Ensure platform meets security, authentication, and file-format needs before eSubmission and supports integrations with EDC and sponsor portals.

Formats: PDF, DOCX, and CSV supported
Integrations: Connectors for EDC, IRB portals, and cloud storage
Authentication: Email links, SMS codes, or SSO options

Typical Timelines and Submission Expectations

Key timing expectations for review, signature collection, submission, and retention associated with the Healthcare Research Form.

IRB initial review window:

Expect 2–8 weeks for full-board review depending on IRB workload and submission completeness.

Consent signature timeframe:

Obtain signed consent before any study procedures begin for each participant.

Adverse event reporting deadline:

Report serious adverse events per sponsor and IRB timelines, often within 24–72 hours.

Data submission to sponsor:

Submit completed case report forms per sponsor schedule and milestone requirements.

Retention and archival period:

Follow sponsor and regulatory requirements for document retention and archival.

Key Risks and Potential Consequences

HIPAA violations: Civil monetary penalties and corrective action

Invalid consent: Participant withdrawals and unusable data

Data breaches: Notification obligations and remediation costs

Regulatory delays: Suspension of enrollment or study hold

Audit findings: Corrective plans and reputational harm

Incorrect patient matching: Data loss or analysis errors

Baseline eSignature Pricing and Feature Comparison

Compare baseline pricing and key features for common eSignature providers to support secure signing and compliance for the Healthcare Research Form.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	Varies by vendor and plan	Varies by vendor and plan	Varies by vendor and plan	Varies by vendor and plan
Bulk Send	Available on select plans	Available on select plans	Available on select plans	Available on select plans	Varies by plan
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA required)	Yes (BAA available)	Yes (BAA available)	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About the Healthcare Research Form

[INTRO] Common questions about legality, signatures, authentication, and retention for the Healthcare Research Form are answered below.

Need help? Contact support

Are electronic signatures legally enforceable?
Yes. Electronic signatures are legally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state UETA laws where adopted; ensure intent, consent, attribution, and reproducible records to meet the legal validity test.
Is a HIPAA Business Associate Agreement required?
Execute a BAA whenever a vendor will create, receive, maintain, or transmit protected health information on behalf of a covered entity. Verify the vendor’s HIPAA compliance posture and obtain a signed BAA before sharing PHI.
Can informed consent be completed electronically?
Electronic informed consent is acceptable when the consent process meets IRB standards and ESIGN requirements, including any consumer-disclosure obligations; document participant access, consent version, and the consent date for auditability.
What signer authentication methods are appropriate?
Acceptable authentication ranges from email links and SMS codes to multi-factor authentication and knowledge-based checks. For regulated records consider stronger methods and follow any applicable 21 CFR Part 11 or sponsor-specific authentication requirements.
How should signed forms be stored and retained?
Store signed records with tamper-evident PDFs, audit trails, and access controls. Retention follows federal standards (HIPAA six years, IRS three years) and sponsor or state requirements; preserve audit data and version history.
What if a participant cannot sign electronically?
Provide alternatives such as witnessed paper signatures, scanned uploads, or assisted signing. Obtain documented consent to use electronic records per ESIGN and record the alternative method used to establish signer intent.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now